Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks?-Reference-Cited by-同舟云学术

Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks?

Published:2013-03 Issue:4 Volume:5 Page:381-383
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Bhardwaj Atul¹,Kaur Jatinder²,Knaus Edward E³

Affiliation:

1. Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada Department of Oncology, University of Alberta, Edmonton, AB, Canada.

2. Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada Department of Oncology, University of Alberta, Edmonton, AB, Canada

3. Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.future-science.com/doi/pdf/10.4155/fmc.13.23

Reference21 articles.

1. Diabetes and Cardiovascular Disease

2. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

3. Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines

4. Diabetes Mellitus and Associated Hypertension, Vascular Disease, and Nephropathy

5. Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tadalafil treatment improves cardiac, renal and lower urinary tract dysfunctions in rats with heart failure;Life Sciences;2022-01

2. Synthesis and Biological Evaluation of 1,3,5‐Trisubstituted 2‐Pyrazolines as Novel Cyclooxygenase‐2 Inhibitors with Antiproliferative Activity;Chemistry & Biodiversity;2021-02-23

3. PDE5 inhibitor sildenafil in the treatment of heart failure: A meta-analysis of randomized controlled trials;International Journal of Cardiology;2014-04

4. The importance of drug discovery for treatment of cardiovascular diseases;Future Medicinal Chemistry;2013-03